Palliative chemotherapy and targeted therapies for esophageal and gastroesophageal junction cancer.
Janmaat VT, Steyerberg EW, van der Gaast A, Mathijssen RH, Bruno MJ, Peppelenbosch MP, Kuipers EJ, Spaander MC.
Cochrane Database Syst Rev. 2017 Nov 28;11(11):CD004063. doi: 10.1002/14651858.CD004063.pub4.
Palliative chemotherapy in head and neck cancer: balancing between beneficial and adverse effects.
Rajendra A, Noronha V, Joshi A, Patil VM, Menon N, Prabhash K.
Expert Rev Anticancer Ther. 2020 Jan;20(1):17-29. doi: 10.1080/14737140.2020.1708197. Epub 2020 Jan 3.
Palliative chemotherapy.
Ellison NM.
Am J Hosp Palliat Care. 1998 Mar-Apr;15(2):93-103. doi: 10.1177/104990919801500208.
Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer.
Verwaal VJ, van Ruth S, de Bree E, van Sloothen GW, van Tinteren H, Boot H, Zoetmulder FA.
J Clin Oncol. 2003 Oct 15;21(20):3737-43. doi: 10.1200/JCO.2003.04.187.
Challenges and Advancements in Palliative Chemotherapy for Ampullary Adenocarcinoma.
Kim EJ.
Gut Liver. 2024 Jul 15;18(4):560-561. doi: 10.5009/gnl240283.
Palliative chemotherapy for recurrent and metastatic esophageal cancer.
Grünberger B, Raderer M, Schmidinger M, Hejna M.
Anticancer Res. 2007 Jul-Aug;27(4C):2705-14.
Chemotherapy Maintenance.
Kasi PM, Grothey A.
Cancer J. 2016 May-Jun;22(3):199-204. doi: 10.1097/PPO.0000000000000195.
Provision of Palliative Combined Pembrolizumab-Chemotherapy in Head and Neck Cancer in England: Time for a Review of the Evidence.
Kelly C, Barnett G, Iqbal MS.
Clin Oncol (R Coll Radiol). 2024 Sep;36(9):534-536. doi: 10.1016/j.clon.2024.05.007. Epub 2024 May 15.
Chemotherapy and other supportive modalities in the palliative setting for pancreatic cancer.
Sullivan KM, Kozuch PS.
Cancer J. 2012 Nov-Dec;18(6):633-41. doi: 10.1097/PPO.0b013e318275896f.
[Palliative chemotherapy].
Osieka R.
Zentralbl Chir. 1998;123(6):714-21.
